• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N 端 HSDCIF 基序是家族 B G 蛋白偶联受体 PAC1 细胞表面运输和二聚化所必需的。

The N-terminal HSDCIF motif is required for cell surface trafficking and dimerization of family B G protein coupled receptor PAC1.

机构信息

Cell Biology Institute, the Department of Cell Biology, Jinan University, Guangzhou, China.

出版信息

PLoS One. 2012;7(12):e51811. doi: 10.1371/journal.pone.0051811. Epub 2012 Dec 21.

DOI:10.1371/journal.pone.0051811
PMID:23284775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3528735/
Abstract

PAC1 is PACAP (pituitary adenylate cyclase-activating polypeptide) preferring receptor belonging to class B G protein coupled receptor (GPCR) mediating the most effects of PACAP. The important role of G protein coupled receptor homo/heteromerization in receptor folding, maturation, trafficking, and cell surface expression has become increasingly evident. The bimolecular fluorescence complementation (BiFC) and bioluminescence resonance energy transfer (BRET) assay were used in this research to confirm the dimerization of PAC1 for the first time. The structure-activity relationship focused on the N-terminal HSDCIF motif, which locates behind the signal sequence and has high homology with PACAP (1-6), was assayed using a receptor mutant with the deletion of the HSDCIF motif. The fluorescence confocal microscope observation showed that the deletion of the HSDCIF motif impaired the cell delivery of PAC1. The results of BiFC, BRET and westernblot indicated that the deletion of HSDCIF motif and the replacement of the Cys residue with Ala in HSDCIF motif resulted in the disruption of receptor dimerization. And the exogenous chemically synthesized oligopeptide HSDCIF (100 nmol/L) not only down-regulated the dimerization of PAC1, induced the internalization of PAC1, but also inhibited the proliferation of CHO cells expressing PAC1 stably and decreased the activity of PACAP on the cell viability. All these data suggested that the N-terminal HSDCIF motif played key role in the trafficking and the dimerization of PAC1, and the exogenous oligopeptide HSDCIF had effects on the cell signaling, trafficking and the dimerization of PAC1.

摘要

PAC1 是 PACAP(垂体腺苷酸环化酶激活肽)优先受体,属于 B 类 G 蛋白偶联受体 (GPCR),介导 PACAP 的大多数作用。G 蛋白偶联受体同/异二聚体在受体折叠、成熟、运输和细胞表面表达中的重要作用已变得越来越明显。本研究首次使用双分子荧光互补 (BiFC) 和生物发光共振能量转移 (BRET) 测定法证实了 PAC1 的二聚化。结构-活性关系集中在 N 端 HSDCIF 基序上,该基序位于信号序列之后,与 PACAP (1-6) 具有高度同源性,使用具有 HSDCIF 基序缺失的受体突变体进行了测定。荧光共聚焦显微镜观察显示,HSDCIF 基序的缺失会损害 PAC1 的细胞传递。BiFC、BRET 和 westernblot 的结果表明,HSDCIF 基序的缺失和 HSDCIF 基序中 Cys 残基的替换导致受体二聚化的破坏。并且外源性化学合成的寡肽 HSDCIF(100 nmol/L)不仅下调了 PAC1 的二聚化,诱导了 PAC1 的内化,而且抑制了稳定表达 PAC1 的 CHO 细胞的增殖,并降低了 PACAP 对细胞活力的活性。所有这些数据表明,N 端 HSDCIF 基序在 PAC1 的运输和二聚化中起关键作用,外源性寡肽 HSDCIF 对 PAC1 的细胞信号转导、运输和二聚化有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/211aa0543143/pone.0051811.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/359534a598ba/pone.0051811.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/cef6f374d6cc/pone.0051811.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/35aa38ed5fcd/pone.0051811.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/c25daded3121/pone.0051811.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/e5eab40a1791/pone.0051811.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/461365597706/pone.0051811.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/3d1e9779e8dc/pone.0051811.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/e12ff8f74ff2/pone.0051811.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/211aa0543143/pone.0051811.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/359534a598ba/pone.0051811.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/cef6f374d6cc/pone.0051811.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/35aa38ed5fcd/pone.0051811.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/c25daded3121/pone.0051811.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/e5eab40a1791/pone.0051811.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/461365597706/pone.0051811.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/3d1e9779e8dc/pone.0051811.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/e12ff8f74ff2/pone.0051811.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a54/3528735/211aa0543143/pone.0051811.g009.jpg

相似文献

1
The N-terminal HSDCIF motif is required for cell surface trafficking and dimerization of family B G protein coupled receptor PAC1.N 端 HSDCIF 基序是家族 B G 蛋白偶联受体 PAC1 细胞表面运输和二聚化所必需的。
PLoS One. 2012;7(12):e51811. doi: 10.1371/journal.pone.0051811. Epub 2012 Dec 21.
2
PACAP induces the dimerization of PAC1 on the nucleus associated with the cAMP increase in the nucleus.PACAP 诱导 PAC1 二聚体在细胞核中形成,同时伴随着细胞核中环腺苷酸(cAMP)的增加。
Neurosci Lett. 2013 Aug 9;549:92-6. doi: 10.1016/j.neulet.2013.06.015. Epub 2013 Jun 20.
3
Dimer-dependent intrinsic/basal activity of the class B G protein-coupled receptor PAC1 promotes cellular anti-apoptotic activity through Wnt/β-catenin pathways that are associated with dimer endocytosis.B类G蛋白偶联受体PAC1的二聚体依赖性内在/基础活性通过与二聚体内吞作用相关的Wnt/β-连环蛋白途径促进细胞抗凋亡活性。
PLoS One. 2014 Nov 26;9(11):e113913. doi: 10.1371/journal.pone.0113913. eCollection 2014.
4
Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP.通过光亲和标记鉴定 PAC1 受体细胞外 N 端结构域为 PACAP 的主要结合位点。
Biochimie. 2011 Apr;93(4):669-77. doi: 10.1016/j.biochi.2010.12.010. Epub 2010 Dec 23.
5
The allosteric modulation effects of doxycycline, minocycline, and their derivatives on the neuropeptide receptor PAC1-R.多西环素、米诺环素及其衍生物对神经肽受体 PAC1-R 的变构调节作用。
Acta Biochim Biophys Sin (Shanghai). 2019 Jun 20;51(6):627-637. doi: 10.1093/abbs/gmz045.
6
The functional recombinant first extracellular (EC1) domain of PACAP receptor PAC1 normal form (PAC1-EC1(N)) recognizes selective ligands and stimulates the proliferation of PAC1-CHO cells.PACP 受体 PAC1 正常形式(PAC1-EC1(N))的功能重组第一细胞外(EC1)结构域识别选择性配体并刺激 PAC1-CHO 细胞的增殖。
Neurosci Lett. 2010 Aug 9;480(1):73-7. doi: 10.1016/j.neulet.2010.06.007. Epub 2010 Jun 8.
7
Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1.强力霉素通过增强神经肽GPCR PAC1的激活发挥神经保护活性。
Neuropharmacology. 2016 Apr;103:1-15. doi: 10.1016/j.neuropharm.2015.11.032. Epub 2015 Dec 15.
8
Blue light induces the nuclear translocation of neuropeptide receptor PAC1-R associated with the up-regulation of PAC1-R its own in reactive oxygen species associated way.蓝光诱导与活性氧相关的神经肽受体 PAC1-R 的核易位,与其自身的上调有关。
Biochim Biophys Acta Gen Subj. 2021 Jun;1865(6):129884. doi: 10.1016/j.bbagen.2021.129884. Epub 2021 Feb 26.
9
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.垂体腺苷酸环化酶激活多肽(PACAP)激活PAC1受体的分子和构象决定因素。
J Med Chem. 2009 May 28;52(10):3308-16. doi: 10.1021/jm900291j.
10
Src family kinase inhibitors blunt PACAP-induced PAC1 receptor endocytosis, phosphorylation of ERK, and the increase in cardiac neuron excitability.Src 家族激酶抑制剂可削弱 PACAP 诱导的 PAC1 受体内吞作用、ERK 的磷酸化以及心脏神经元兴奋性的增加。
Am J Physiol Cell Physiol. 2018 Feb 1;314(2):C233-C241. doi: 10.1152/ajpcell.00223.2017. Epub 2017 Nov 15.

引用本文的文献

1
Comprehensive Review on Bimolecular Fluorescence Complementation and Its Application in Deciphering Protein-Protein Interactions in Cell Signaling Pathways.双分子荧光互补及其在破译细胞信号通路中蛋白质-蛋白质相互作用的应用的综合综述。
Biomolecules. 2024 Jul 17;14(7):859. doi: 10.3390/biom14070859.
2
Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP.正向变构调节 PAC1-R 可上调 PAC1-R 及其特定配体 PACAP。
Acta Biochim Biophys Sin (Shanghai). 2022 May 25;54(5):657-672. doi: 10.3724/abbs.2022041.
3
Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.

本文引用的文献

1
Receptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity.B1 家族 G 蛋白偶联受体的受体寡聚化:BRET 研究的焦点及 GPCR 寡聚化与结合协同性之间的联系。
Front Endocrinol (Lausanne). 2012 May 7;3:62. doi: 10.3389/fendo.2012.00062. eCollection 2012.
2
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.血管活性肠肽和垂体腺苷酸环化酶激活肽受体的药理学和功能:国际药理学联合会评论 1。
Br J Pharmacol. 2012 May;166(1):4-17. doi: 10.1111/j.1476-5381.2012.01871.x.
3
三叉血管系统中的垂体腺苷酸环化酶激活多肽受体:与偏头痛的关系。
Br J Pharmacol. 2018 Nov;175(21):4109-4120. doi: 10.1111/bph.14053. Epub 2017 Oct 25.
4
The palmitoylation of the N-terminal extracellular Cys37 mediates the nuclear translocation of VPAC1 contributing to its anti-apoptotic activity.N 端胞外半胱氨酸 37 的棕榈酰化介导了 VPAC1 的核转位,这有助于其抗凋亡活性。
Oncotarget. 2017 Jun 27;8(26):42728-42741. doi: 10.18632/oncotarget.17449.
5
Dimer-dependent intrinsic/basal activity of the class B G protein-coupled receptor PAC1 promotes cellular anti-apoptotic activity through Wnt/β-catenin pathways that are associated with dimer endocytosis.B类G蛋白偶联受体PAC1的二聚体依赖性内在/基础活性通过与二聚体内吞作用相关的Wnt/β-连环蛋白途径促进细胞抗凋亡活性。
PLoS One. 2014 Nov 26;9(11):e113913. doi: 10.1371/journal.pone.0113913. eCollection 2014.
6
Neuroprotection of a novel cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosis.新型环肽C*HSDGIC*(由垂体腺苷酸环化酶激活肽(1-5)环化而成)在视网膜神经节细胞凋亡的细胞和啮齿动物模型中的神经保护作用。
PLoS One. 2014 Oct 6;9(10):e108090. doi: 10.1371/journal.pone.0108090. eCollection 2014.
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor.
创伤后应激障碍与 PACAP 和 PAC1 受体有关。
Nature. 2011 Feb 24;470(7335):492-7. doi: 10.1038/nature09856.
4
Region-specific changes in the immunoreactivity of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC2, and PAC1 receptor) in the aged rat brains.老年大鼠脑内血管活性肠肽和垂体腺苷酸环化酶激活肽受体(VPAC2 和 PAC1 受体)免疫反应性的区域特异性变化。
Brain Res. 2010 Sep 10;1351:32-40. doi: 10.1016/j.brainres.2010.06.048. Epub 2010 Jul 1.
5
The functional recombinant first extracellular (EC1) domain of PACAP receptor PAC1 normal form (PAC1-EC1(N)) recognizes selective ligands and stimulates the proliferation of PAC1-CHO cells.PACP 受体 PAC1 正常形式(PAC1-EC1(N))的功能重组第一细胞外(EC1)结构域识别选择性配体并刺激 PAC1-CHO 细胞的增殖。
Neurosci Lett. 2010 Aug 9;480(1):73-7. doi: 10.1016/j.neulet.2010.06.007. Epub 2010 Jun 8.
6
A novel cyclopeptide from the cyclization of PACAP(1-5) with potent activity towards PAC1 attenuates STZ-induced diabetes.一种新型环肽,由 PACAP(1-5)环化而成,对 PAC1 具有活性,可减弱 STZ 诱导的糖尿病。
Peptides. 2010 Jun;31(6):1062-7. doi: 10.1016/j.peptides.2010.03.008. Epub 2010 Mar 20.
7
Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide.垂体腺苷酸环化酶激活肽:聚焦于神经保护肽的结构-活性关系。
Curr Med Chem. 2009;16(33):4462-80. doi: 10.2174/092986709789712899.
8
Effects of pituitary adenylate cyclase activating polypeptide on the survival and signal transduction pathways in human choriocarcinoma cells.垂体腺苷酸环化酶激活多肽对人绒毛膜癌细胞存活及信号转导通路的影响。
Ann N Y Acad Sci. 2009 Apr;1163:353-7. doi: 10.1111/j.1749-6632.2008.03630.x.
9
Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor.B族G蛋白偶联促胰液素受体结构独特的同二聚体复合物的功能重要性
Mol Pharmacol. 2009 Aug;76(2):264-74. doi: 10.1124/mol.109.055756. Epub 2009 May 8.
10
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.垂体腺苷酸环化酶激活多肽(PACAP)激活PAC1受体的分子和构象决定因素。
J Med Chem. 2009 May 28;52(10):3308-16. doi: 10.1021/jm900291j.